WHO & Regional Offices [to 14 Aug 2021]

WHO & Regional Offices [to 14 Aug 2021]
13 August 2021
Medical product alert
Medical Product Alert N°4/2021: Falsified remdesivir

12 August 2021
Statement
WHO Statement on advancing the next series of studies to find the origins of SARS-CoV-2
[See COVID above for detail]

12 August 2021
Departmental news
International Youth Day 2021: Quality data crucial for improving adolescents’ health and well-being in countries across the world

11 August 2021
News release
WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs
[See COVID above for detail]

11 August 2021
Departmental news
WHO, Facebook and Praekelt.Org provide critical mobile access to COVID-19 information for vulnerable communities

10 August 2021
Statement
Interim statement on COVID-19 vaccine booster doses
[See COVID above for detail]

10 August 2021
Statement
Interim statement on dose-sparing strategies for COVID-19 vaccines (fractionated vaccine doses)
[See COVID above for detail]

10 August 2021
Statement
Interim statement on heterologous priming for COVID-19 vaccines
[See COVID above for detail]

10 August 2021
Medical product alert
Medical Product Alert N°3/2021: Falsified CYTOTEC

10 August 2021
Departmental news
Target product profile for next-generation TB drug-susceptibility testing at peripheral sites

9 August 2021
Departmental news
West Africa’s first-ever case of Marburg virus disease confirmed in Guinea

::::::

 

WHO Regional Offices
Selected Press Releases, Announcements
WHO African Region AFRO
No new digest content identified

WHO Region of the Americas PAHO
No new digest content identified

WHO South-East Asia Region SEARO
No new digest content identified

WHO European Region EURO
:: Health advice: wildfires in the WHO European Region 12-08-2021

WHO Eastern Mediterranean Region EMRO
No new digest content identified

WHO Western Pacific Region
No new digest content identified

 

::::::

New WHO Publications [Selected]
https://www.who.int/publications/i

 

Weekly epidemiological record vol. 29, 2021, 96, 321–328
14 August 2021
Overview
The Global Advisory Committee on Vaccine Safety (GACVS), an independent expert clinical and scientific advisory body, provides WHO with scientifically rigorous advice on vaccine safety issues of potential global importance; provides scientific safety recommendations for policy-making by WHO, the WHO Strategic Advisory Group of Experts (SAGE) on immunization, national governments and international organizations; recommends the creation of ad hoc task forces for methodological and empirical research into potential adverse events and prioritizes aspects of vaccine safety to be monitored during their use.
The 44th GACVS meeting on 8–9 June 2021, held online, addressed a number of pharmacovigilance issues, including the following:
– GACVS COVID-19 Sub-committee
– COVID-19 vaccine-related events early warning system
– Safety profile of nOPV2 vaccine

 

Guidance for surveillance of SARS-CoV-2 variants: Interim guidance, 9 August 2021
Overview
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators is also provided to standardize monitoring and public reporting of variant circulation…

 

Considerations for health governance: strengthening institutional capacity and connectedness through COVID-19 responses
5 August 2021  | Technical document
Overview
Coronavirus disease 2019 (‎COVID-19)‎ requires effective whole-of-government and whole-of-society action and collaboration. Legal frameworks play a critical role in enabling this, including by ensuring government accountability and transparency, establishing roles and responsibilities, enabling coordination, supporting evidence-based decision-making, and providing for the engagement of the community and the private sector. This document suggests actions for WHO and Member States to work together to strengthen legal frameworks to support leadership and governance for the COVID-19 response and to achieve Universal Health Coverage beyond the pandemic.